The $200 Billion Signal Most BizDev Teams Miss Every Year: Why drug patent loss-of-exclusivity alerts are the competitive intelligence tool biopharma business development can no longer afford to ignore
The $200 Billion Signal Most BizDev Teams Miss Every Year — And How to Capture It
In the high-stakes world of biopharma, billions of dollars are on the line every year. Yet, despite the enormous financial stakes, many business development teams are sti…
